1. Home
  2. RR vs DRUG Comparison

RR vs DRUG Comparison

Compare RR & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Richtech Robotics Inc. Class B

RR

Richtech Robotics Inc. Class B

N/A

Current Price

$2.30

Market Cap

614.9M

Sector

N/A

ML Signal

N/A

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

N/A

Current Price

$61.37

Market Cap

707.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RR
DRUG
Founded
2016
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
614.9M
707.1M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
RR
DRUG
Price
$2.30
$61.37
Analyst Decision
Hold
Strong Buy
Analyst Count
2
6
Target Price
$4.00
$129.25
AVG Volume (30 Days)
12.7M
421.2K
Earning Date
05-13-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,045,000.00
N/A
Revenue This Year
$75.68
N/A
Revenue Next Year
$78.28
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.99
N/A
52 Week Low
$1.73
$23.18
52 Week High
$7.43
$123.75

Technical Indicators

Market Signals
Indicator
RR
DRUG
Relative Strength Index (RSI) 42.67 28.08
Support Level $1.85 $49.47
Resistance Level $2.93 $61.76
Average True Range (ATR) 0.25 5.26
MACD -0.09 -1.94
Stochastic Oscillator 16.67 5.40

Price Performance

Historical Comparison
RR
DRUG

About RR Richtech Robotics Inc. Class B

Richtech Robotics Inc is a robotics and artificial intelligence (AI) technology company focused on developing embodied AI systems that aims to improve the efficiency and productivity of businesses. The company trains proprietary artificial intelligence models on in-house data to operate robotic systems in the real world. It designs, engineers, manufactures, and deploys next generation embodied AI systems to serve a wide range of industries, including food service, retail, industrial manufacturing, automotive, healthcare, and hospitality. The company's offerings include Commercial Robotic Products, Industrial Robotic Products and Data Services. The company generated the majority of its revenue through product revenue (i.e. outright hardware sales).

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: